Actithera
Actithera is a molecular radiotherapeutic company that develops radioligand therapies.
$75.5M Series A ·
Led by 4BIO Capital · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJul 12, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $75.5M | fundraisingfox.com |
Timeline
- Website created
Founders and team
AG
Andreas Goutopoulos FounderDD
Darshan Dalal Chief Medical Officer
Investors
44BIO Capitallead investor
AArkin Bio Ventures
BBioqube Ventures
HHadean Ventureslead investor
IInnovestor
IInvestinor
MM Ventureslead investor
SSofinnova Partnerslead investor
SSurveyor Capital
Companies like Actithera
AARTBIO$132M Series B+ · Jul 2025
MMariana Oncology$175M Series B+ · Sep 2023
OOna Therapeutics$86.6M Series B+ · Oct 2026
BBreakthru Medicine$60M Series A · Feb 2026
MMyosin Therapeutics$3M Seed · Mar 2025
Other companies backed by 4BIO Capital
OOyster Therapeutics$60M Series A · Nov 2026
EEstuary Biotherapeutics$103M Series A · Oct 2026
UUndecimal Bio$18M Seed · Oct 2026
AAptadir Therapeutics$45M Seed · Sep 2026
CCloverleaf Bio$33M Seed · Sep 2026
VViaNautisSeries A · Oct 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/actithera (get a free API key).